Follow
Keisuke Kamada
Keisuke Kamada
The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association
Verified email at jata.or.jp
Title
Cited by
Cited by
Year
Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva
S Iwasaki, S Fujisawa, S Nakakubo, K Kamada, Y Yamashita, T Fukumoto, ...
Journal of Infection 81 (2), e145-e147, 2020
2742020
Candida auris: a pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains
S Iguchi, Y Itakura, A Yoshida, K Kamada, R Mizushima, Y Arai, Y Uzawa, ...
Journal of Infection and Chemotherapy 25 (10), 743-749, 2019
602019
Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification
T Fukumoto, S Iwasaki, S Fujisawa, K Hayasaka, K Sato, S Oguri, K Taki, ...
International Journal of Infectious Diseases 98, 16-17, 2020
482020
Purulent lymphadenitis caused by Staphylococcus argenteus, representing the first Japanese case of Staphylococcus argenteus (multilocus sequence type 2250) infection in a 12 …
T Ohnishi, M Shinjoh, H Ohara, T Kawai, I Kamimaki, R Mizushima, ...
Journal of infection and chemotherapy 24 (11), 925-927, 2018
272018
Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan
K Kamada, A Yoshida, S Iguchi, Y Arai, Y Uzawa, S Konno, M Shimojima, ...
Scientific reports 11 (1), 12208, 2021
232021
The second Candida auris isolate from aural discharge in Japan
S Iguchi, R Mizushima, K Kamada, Y Itakura, A Yoshida, Y Uzawa, Y Arai, ...
Japanese Journal of Infectious Diseases 71 (2), 174-175, 2018
222018
Associations of COVID-19 symptoms with omicron subvariants BA. 2 and BA. 5, host status, and clinical outcomes in Japan: a registry-based observational study
S Nakakubo, N Kishida, K Okuda, K Kamada, M Iwama, M Suzuki, ...
The Lancet Infectious Diseases 23 (11), 1244-1256, 2023
182023
Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia
A Yuno, Y Kenmotsu, Y Takahashi, H Nomoto, H Kameda, KY Cho, ...
Endocrine Journal 68 (4), 477-484, 2021
182021
Comparative efficacy of tocilizumab and baricitinib administration in COVID-19 treatment: a retrospective cohort study
Y Kojima, S Nakakubo, N Takei, K Kamada, Y Yamashita, J Nakamura, ...
Medicina 58 (4), 513, 2022
152022
Geographical distribution and regional differences in 532 clinical isolates of rapidly growing mycobacterial species in Japan
K Kamada, A Yoshida, S Iguchi, Y Arai, Y Uzawa, S Konno, M Shimojima, ...
Scientific reports 11 (1), 4960, 2021
152021
Rapidly progressive organizing pneumonia associated with COVID-19
H Horii, K Kamada, S Nakakubo, Y Yamashita, J Nakamura, Y Nasuhara, ...
Respiratory Medicine Case Reports 31, 101295, 2020
132020
Proposal of COVID-19 Clinical Risk Score for the management of suspected COVID-19 cases: a case control study
S Nakakubo, M Suzuki, K Kamada, Y Yamashita, J Nakamura, H Horii, ...
BMC infectious diseases 20, 1-11, 2020
122020
Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child
S Myojin, K Fukuoka, A Kanemaru, S Baba, Y Okamoto, H Suzuki, ...
International Journal of Infectious Diseases 74, 10-12, 2018
92018
Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID‐19: A retrospective study
Y Kojima, S Nakakubo, K Kamada, Y Yamashita, N Takei, J Nakamura, ...
Journal of Medical Virology 94 (12), 5702-5712, 2022
72022
Effect of varying storage conditions on diagnostic test outcomes of SARS-CoV-2
S Oguri, S Fujisawa, K Kamada, S Nakakubo, Y Yamashita, J Nakamura, ...
Journal of Infection 83 (1), 119-145, 2021
72021
Pulmonary infection due to fluoroquinolone-resistant Mycolicibacterium fortuitum: a case report
K Kurokawa, N Harada, H Sasano, H Takagi, S Takei, A Nakamura, ...
BMC Infectious Diseases 20, 1-6, 2020
72020
Purpura fulminans with Lemierre’s syndrome caused by Gemella bergeri and Eikenella corrodens: a case report
T Yamagishi, M Hikone, K Sugiyama, T Tanabe, Y Wada, M Furugaito, ...
BMC infectious diseases 18, 1-7, 2018
62018
Multiple introductions of SARS-CoV-2 B. 1.1. 214 lineages from mainland Japan preceded the third wave of the COVID-19 epidemic in Hokkaido
T Shimura, K Abe, T Takenouchi, M Yamada, H Suzuki, M Suematsu, ...
Travel Medicine and Infectious Disease 44, 102210, 2021
52021
Older age is associated with sustained detection of SARS-CoV-2 in nasopharyngeal swab samples
T Hattori, M Amishima, D Morinaga, K Kamada, S Nakakubo, Y Yamashita, ...
Journal of Infection 82 (1), 159-198, 2021
52021
2051. Detection of Candida auris Among Previously Unidentified Yeasts Isolated from Ear Discharge Specimens in Japan
S Iguchi, R Mizushima, K Kamada, Y Itakura, A Yoshida, Y Uzawa, Y Arai, ...
Open Forum Infectious Diseases 5 (suppl_1), S598-S599, 2018
52018
The system can't perform the operation now. Try again later.
Articles 1–20